scholarly article | Q13442814 |
P50 | author | Christian Heim | Q43002929 |
P2093 | author name string | R Müller | |
J Hoffmann | |||
T Stamminger | |||
M Weyand | |||
B M Spriewald | |||
M Leis | |||
M Wollin | |||
S M Ensminger | |||
S Abele-Ohl | |||
S Mahmoudian | |||
P2860 | cites work | HCMV-infection in a human arterial organ culture model: effects on cell proliferation and neointimal hyperplasia | Q33292028 |
Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b | Q33799527 | ||
Coronary artery disease in the transplanted heart | Q33895982 | ||
Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts | Q34169756 | ||
The human cytomegalovirus ribonucleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by a BAC-cloned clinical isolate of human cytomegalovirus with preserved wild-type characteristics | Q34345137 | ||
Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants | Q34467148 | ||
Cytomegalovirus and transplant arteriopathy: evidence for a link is mounting, but the jury is still out. | Q35096458 | ||
Immunopathology of human T cell responses to skin, artery and endothelial cell grafts in the human peripheral blood lymphocyte/severe combined immunodeficient mouse | Q35211612 | ||
The role of viruses in cardiac allograft vasculopathy | Q35671637 | ||
Current understanding and management of allograft vasculopathy | Q36001190 | ||
Immune activation following cytomegalovirus infection: more important than direct viral effects in cardiovascular disease? | Q36357628 | ||
Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and beta1 and beta3 integrins | Q36535574 | ||
Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing | Q37220021 | ||
Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection | Q41913861 | ||
Deletion of open reading frame UL26 from the human cytomegalovirus genome results in reduced viral growth, which involves impaired stability of viral particles | Q41947389 | ||
Synergistic induction of intercellular adhesion molecule-1 by the human cytomegalovirus transactivators IE2p86 and pp71 is mediated via an Sp1-binding site | Q42049262 | ||
Murine cytomegalovirus infection leads to increased levels of transplant arteriosclerosis in a murine aortic allograft model | Q43002865 | ||
Cytomegalovirus accelerates chronic allograft nephropathy in a rat renal transplant model with associated provocative chemokine profiles | Q43416695 | ||
The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function | Q44322674 | ||
Heart and lung transplantation in the United States, 1997-2006. | Q44412320 | ||
Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice | Q45016192 | ||
Prophylaxis versus preemptive therapy for prevention of the consequences of cytomegalovirus infection in transplant recipients: a still unresolved issue | Q45062894 | ||
The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration | Q45863859 | ||
The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report--2010. | Q45945360 | ||
Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients. | Q46024867 | ||
Human cytomegalovirus infection in human renal arteries in vitro | Q48001832 | ||
Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. | Q53592113 | ||
Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection. | Q54587707 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cytomegaloviral disease | Q2076966 |
Cytomegalovirus | Q6946 | ||
xenograft | Q64148587 | ||
P304 | page(s) | 1720-1729 | |
P577 | publication date | 2012-03-19 | |
P1433 | published in | American Journal of Transplantation | Q4744273 |
P1476 | title | Human cytomegalovirus infection leads to elevated levels of transplant arteriosclerosis in a humanized mouse aortic xenograft model | |
P478 | volume | 12 |
Q35139237 | A human lung xenograft mouse model of Nipah virus infection |
Q34369349 | A method for quantifying mechanical properties of tissue following viral infection |
Q34135605 | Generation of improved humanized mouse models for human infectious diseases |
Q39329450 | Humanized mice: A brief overview on their diverse applications in biomedical research. |
Q36142747 | Humanized mouse models of human cytomegalovirus infection |
Q44117675 | Procurement regimens to reduce ischemia reperfusion injury of vascular grafts |
Q43112327 | Viral infection at the endothelium |
Search more.